Impoyz (clobetasol) / Encore - LARVOL DELTA

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06 (clinicaltrials.gov) - P2; N=22; Terminated; Sponsor: Encore Dermatology, Inc.; N=50 ➔ 22; Trial completion date: Jun 2019 ➔ Jun 2020; Recruiting ➔ Terminated; Difficulty in enrollment

Clinical • Enrollment change • Trial completion date • Trial termination • Dermatology • Immunology • Pediatrics • Psoriasis

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate Plaque Psoriasis (clinicaltrials.gov) - P3; N=264; Not yet recruiting; Sponsor: Promius Pharma, LLC; Initiation date: May 2015 ➔ Oct 2015

Trial initiation date • Biosimilar • Immunology • Inflammation • Psoriasis

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate Plaque Psoriasis (clinicaltrials.gov) - P3; N=264; Not yet recruiting; Sponsor: Promius Pharma, LLC

New P3 trial • Biosimilar • Immunology • Inflammation • Psoriasis

"Metallica cancel Australia, New Zealand tour as Hetfield enters rehab https://t.co/7rDdFD06jZ" (@Reuters)

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06 (clinicaltrials.gov) - P2; N=50; Recruiting; Sponsor: Encore Dermatology, Inc.; Trial completion date: May 2018 ➔ Jun 2019; Trial primary completion date: May 2018 ➔ Jun 2019

Clinical • Trial completion date • Trial primary completion date